InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2023-01-23 | Shri Thanedar(D-MI13) | house | Sale | $1,001 - $15,000 |
No financial data available for CMPS.
Company may not file with SEC or CIK is unresolved.
Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver?
Error: Response status code does not indicate success: 503 (Service Unavailable).
Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit
These 3 Psychedelic Stocks Activated After Trump's Executive Order
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
FDA Grants Rolling Review and CNPV Designation to Compass Pathways (CMPS) for TRD Treatment
Trending stocks this week as markets weigh war risks and corporate results
FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit.
Sector Update: Health Care Stocks Fall Late Afternoon
Sector Update: Health Care Stocks Decline in Afternoon Trading
COMPASS Pathways psilocybin asset for depression awarded Commissioner voucher
Compass Pathways: Red Hot Psychedelic Market For Pioneer With Near Term Psychedelic Filing In TRD